Bruna Garbes Goncalves Pinto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bruna Garbes Goncalves Pinto has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Artur José Marques Paulo
Hospital Israelita Albert Einstein São Paulo SP Brazil
3 shared publications - Joselisa Péres Queiroz de Paiva
Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
3 shared publications - Rafael Maffei Loureiro
Department of Radiology, Hospital Israelita Albert Einstein, Sao Paulo, Brazil
3 shared publications - Klaus Schumacher
Hospital Israelita Albert Einstein
2 shared publications - Pedro Vinicius Alves Silva Silva
Department of Radiology, Hospital Israelita Albert Einstein, Av. Albert Einstein 627, Bldg. D, 4th Floor, 627/701, São Paulo, São Paulo, 05652-900, Brazil, 55 11998314571
2 shared publications - Tayran Mila Mendes Olegario
Hospital Israelita Albert Einstein
2 shared publications
Latest Publications
- 19 September 2025
- Published by Springer Nature
- p. 177-186
Assessing Annotator and Clinician Biases in an Open-Source-Based Tool Used to Generate Head CT Segmentations for Deep Learning Training
- 19 September 2025
- Published by Springer Nature
- p. 177-186
Assessing Annotator and Clinician Biases in an Open-Source-Based Tool Used to Generate Head CT Segmentations for Deep Learning Training
- Open Access
- 27 June 2025
- Published by Elsevier in NeuroImage
- Vol. 317, 121272
Age- and sex-specific normative curves for intracranial and ventricular volumes from head CT scans
- 27 June 2025
- Published by Elsevier in NeuroImage
- Vol. 317, 121272
Open AccessAge- and sex-specific normative curves for intracranial and ventricular volumes from head CT scans
- 1 October 2023
- Published by Springer Nature
- p. 112-122
Brain Age Prediction Based on Head Computed Tomography Segmentation
- 1 October 2023
- Published by Springer Nature
- p. 112-122
Brain Age Prediction Based on Head Computed Tomography Segmentation
- Top Cited Papers
- 11 June 2020
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 222 (4) , 556-563
ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19
Patients who died from COVID-19 often had comorbidities, such as hypertension, diabetes, and chronic obstructive lung disease. Although angiotensin-converting enzyme 2 (ACE2) is crucial for SARS-CoV-2 to bind and enter host cells, no study has systematically assessed the ACE2 expression in the lungs of patients with these diseases. Here, we analyzed over 700 lung transcriptome samples from patients with comorbidities associated with severe COVID-19 and found that ACE2 was highly expressed in these patients compared to control individuals. This finding suggests that patients with such comorbidities may have higher chances of developing severe COVID-19. Correlation and network analyses revealed many potential regulators of ACE2 in the human lung, including genes related to histone modifications, such as HAT1, HDAC2, and KDM5B. Our systems biology approach offers a possible explanation for increased COVID-19 severity in patients with certain comorbidities.
- 11 June 2020
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 222 (4) , 556-563
Top Cited PapersACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19
Patients who died from COVID-19 often had comorbidities, such as hypertension, diabetes, and chronic obstructive lung disease. Although angiotensin-converting enzyme 2 (ACE2) is crucial for SARS-CoV-2 to bind and enter host cells, no study has systematically assessed the ACE2 expression in the lungs of patients with these diseases. Here, we analyzed over 700 lung transcriptome samples from patients with comorbidities associated with severe COVID-19 and found that ACE2 was highly expressed in these patients compared to control individuals. This finding suggests that patients with such comorbidities may have higher chances of developing severe COVID-19. Correlation and network analyses revealed many potential regulators of ACE2 in the human lung, including genes related to histone modifications, such as HAT1, HDAC2, and KDM5B. Our systems biology approach offers a possible explanation for increased COVID-19 severity in patients with certain comorbidities.
- Open Access
- 14 February 2020
- Published by Springer Nature in Molecular Psychiatry
- Vol. 26 (5) , 1589-1605
Transcriptome of iPSC-derived neuronal cells reveals a module of co-expressed genes consistently associated with autism spectrum disorder
Evaluation of expression profile in autism spectrum disorder (ASD) patients is an important approach to understand possible similar functional consequences that may underlie disease pathophysiology regardless of its genetic heterogeneity. Induced pluripotent stem cell (iPSC)-derived neuronal models have been useful to explore this question, but larger cohorts and different ASD endophenotypes still need to be investigated. Moreover, whether changes seen in this in vitro model reflect previous findings in ASD postmortem brains and how consistent they are across the studies remain underexplored questions. We examined the transcriptome of iPSC-derived neuronal cells from a normocephalic ASD cohort composed mostly of high-functioning individuals and from non-ASD individuals. ASD patients presented expression dysregulation of a module of co-expressed genes involved in protein synthesis in neuronal progenitor cells (NPC), and a module of genes related to synapse/neurotransmission and a module related to translation in neurons. Proteomic analysis in NPC revealed potential molecular links between the modules dysregulated in NPC and in neurons. Remarkably, the comparison of our results to a series of transcriptome studies revealed that the module related to synapse has been consistently found as upregulated in iPSC-derived neurons—which has an expression profile more closely related to fetal brain—while downregulated in postmortem brain tissue, indicating a reliable association of this network to the disease and suggesting that its dysregulation might occur in different directions across development in ASD individuals. Therefore, the expression pattern of this network might be used as biomarker for ASD and should be experimentally explored as a therapeutic target.
- 14 February 2020
- Published by Springer Nature in Molecular Psychiatry
- Vol. 26 (5) , 1589-1605
Open AccessTranscriptome of iPSC-derived neuronal cells reveals a module of co-expressed genes consistently associated with autism spectrum disorder
Evaluation of expression profile in autism spectrum disorder (ASD) patients is an important approach to understand possible similar functional consequences that may underlie disease pathophysiology regardless of its genetic heterogeneity. Induced pluripotent stem cell (iPSC)-derived neuronal models have been useful to explore this question, but larger cohorts and different ASD endophenotypes still need to be investigated. Moreover, whether changes seen in this in vitro model reflect previous findings in ASD postmortem brains and how consistent they are across the studies remain underexplored questions. We examined the transcriptome of iPSC-derived neuronal cells from a normocephalic ASD cohort composed mostly of high-functioning individuals and from non-ASD individuals. ASD patients presented expression dysregulation of a module of co-expressed genes involved in protein synthesis in neuronal progenitor cells (NPC), and a module of genes related to synapse/neurotransmission and a module related to translation in neurons. Proteomic analysis in NPC revealed potential molecular links between the modules dysregulated in NPC and in neurons. Remarkably, the comparison of our results to a series of transcriptome studies revealed that the module related to synapse has been consistently found as upregulated in iPSC-derived neurons—which has an expression profile more closely related to fetal brain—while downregulated in postmortem brain tissue, indicating a reliable association of this network to the disease and suggesting that its dysregulation might occur in different directions across development in ASD individuals. Therefore, the expression pattern of this network might be used as biomarker for ASD and should be experimentally explored as a therapeutic target.